This central position to orchestrate hallmarks of life may explain why RAS is so frequently exploited in cancer, where the three RAS genes, KRAS, NRAS and HRAS combined are mutated in 19% of cancer patients [2]. The gene discussed is KRAS; the disease is cancer.